Academic Journal

Antibodies response induced by recombinant virus-like particles from Triatoma virus and chimeric antigens from Trypanosoma cruzi

التفاصيل البيبلوغرافية
العنوان: Antibodies response induced by recombinant virus-like particles from Triatoma virus and chimeric antigens from Trypanosoma cruzi
المؤلفون: Queiroz, Aline Maria Vasconcelos, Yanshina, Yulia Aleksandrovna, Rodrigues, Emily Thays da Silva, Santos, Fred Luciano Neves, Fiorani Celedon, Paola Alejandra, Maheshwari, Sweta, Gabelli, Sandra Beatriz, Peucelle Rubio, Carla Stephanie, Durana, Aritz, Guérin, Diego M. A., Silva, Marcelo Sousa
المساهمون: Consejo Superior de Investigaciones Científicas (España), Global Health and Tropical Medicine (Portugal), Comisión Asesora de Investigación Científica y Técnica, CAICYT (España), Universidad del País Vasco, Eusko Jaurlaritza, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (Brasil)
بيانات النشر: Elsevier
سنة النشر: 2021
المجموعة: Digital.CSIC (Consejo Superior de Investigaciones Científicas / Spanish National Research Council)
مصطلحات موضوعية: Adjuvant, Chagas disease, Humoral immune responses, Triatoma virus, Trypanosoma cruzi, Virus-like particles (VLPs)
الوصف: The infection caused by the protozoan Trypanosoma cruzi affects humans and is called as Chagas disease. Currently, the main measures available to reduce the incidence of this disease are drug treatment and vector control. Traditionally, the development of vaccines occurs mainly through the use of antigenic candidates of the etiologic agent in the form of a vaccine preparation. Virus-like particles (VLPs) are structures analogous to viral capsids composed essentially of structural proteins and are widely used in vaccination protocols because of their immunostimulatory properties. In this context, the objective of this study was to use strategies in a murine immunization model to characterize the immunostimulatory capacity of VLPs from Triatoma virus (TrV-VLPs), analysed in the presence or absence of the aluminium vaccine adjuvant. In parallel, to characterize the immunogenic behaviour of four T. cruzi chimeric recombinant proteins (mix-IBMP) associated with TrV-VLPs or aluminium vaccine adjuvant. ; This research was funded by Consejo Superior de Investigaciones Científicas (grant number COOPB20503 - CSIC, Spain) and Global Health and Tropical Medicine [grant number GHTM-UID/multi/04413/2013] and partially supported by grants to DMAG, from the Ministerio de Ciencia e Innovación [BFU2012-36241], Grupos Investigación UPV/EHU 2018 [GIU18/172], and Gobierno Vasco [Elkartek KK-2017/00008], Programa de empresas Innovadoras A1 2020 EKINZAILE, The Basque Country, Spain. This study also was supported by Coordenação de Aperfeiçaomento de Pessoal de Nível Superior (CAPES, Brazil). ; Peer reviewed
نوع الوثيقة: article in journal/newspaper
اللغة: English
تدمد: 0264-410X
Relation: https://doi.org/10.1016/j.vaccine.2021.05.039; Sí; Vaccine 39(33): 4723-4732 (2021); http://hdl.handle.net/10261/310228; http://dx.doi.org/10.13039/501100003086; http://dx.doi.org/10.13039/501100007272; http://dx.doi.org/10.13039/501100003339; http://dx.doi.org/10.13039/501100002322; 2-s2.0-85107155224; https://api.elsevier.com/content/abstract/scopus_id/85107155224
DOI: 10.1016/j.vaccine.2021.05.039
DOI: 10.13039/501100003086
DOI: 10.13039/501100007272
DOI: 10.13039/501100003339
DOI: 10.13039/501100002322
الاتاحة: http://hdl.handle.net/10261/310228
https://doi.org/10.1016/j.vaccine.2021.05.039
https://doi.org/10.13039/501100003086
https://doi.org/10.13039/501100007272
https://doi.org/10.13039/501100003339
https://doi.org/10.13039/501100002322
https://api.elsevier.com/content/abstract/scopus_id/85107155224
Rights: none
رقم الانضمام: edsbas.57E5D91E
قاعدة البيانات: BASE
الوصف
تدمد:0264410X
DOI:10.1016/j.vaccine.2021.05.039